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Abstract 
N6-(1,3-dioxolancarbonyl)lysine was synthesized and incorporated into full-length mCherry and 
α-synuclein proteins by reading through a UAG codon. Mass spectrometry analysis confirmed 
that the analog incorporates into α-synuclein in the acetal form. Two additional pyrrolysine 
analogs, N6-(2-oxo-2H-chromene-3-oyl)lysine trifluoroacetate and N6-(aminoxyacetoyl)lysine 
ditrifluoroacetate, were synthesized but neither compound reads through the UAG codon. 
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1. Introduction 
Pyrrolysine (1, Figure 1), the 22nd genetically-encoded amino acid, was discovered by the 
laboratory of Professor Michael K. Chan in collaboration with the laboratory of Professor Joseph 
Krzycki in 2002.1,2 Pyrrolysine has since been incorporated into recombinant proteins in E. coli 
by reading through the UAG codon.3 In addition, various pyrrolysine analogs (2-6, Figure 1) 
have been successfully synthesized, some of which (2, 4-6) have been incorporated into 
recombinant proteins.4,5 
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Figure 1: Pyrrolysine (1) and its synthetic analogs (2-6). 
In order to attempt to introduce an aldehyde functionality into a protein system, a new target 
pyrrolysine analog, N6-(1,3-dioxolancarbonyl)lysine (7), was chosen. 
 
This analog was chosen because of its steric and electronic similarity to pyrrolysine, 
chemical stability, and lack of a chiral center at the N6 substituent of lysine. In addition, this 
target analog contains an acetal which potentially could be converted to an aldehyde under acidic 
conditions. Once the aldehyde is unmasked, a hydrazine dye could be used to tag the protein via 
hydrazone formation. Areas of specific proteins, such as α-synuclein, which appear to have salt 
bridges between neighboring lysine and glutamate residues could then be studied. In order to 
                                                 
1G. Srinivasan, C. M. James, J. A. Kryzycki, Science 2002, 296, 1459–1462. 
2B. Hao, W. Gong, T. K. Ferguson, C. M. James, J. A. Krzycki, M. K. Chan, Science 2002, 296, 1462–1466. 
3S. K. Blight, R. C. Larue, A. Mahapatra, D. G. Longstaff, E. Chang, G. Zhao, P. T. Kang, K. B. Green-Church, M. 
K. Chan, J. A. Krzycki, Nature 2004, 431, 333–335.  
4C. R. Polycarpo, S. Herring, A. Berube, J. L. Wood, D. Soll, A. Ambrogelly, FEBS 2006, 580, 6695–6700. 
5T. Fekner, X. Li, M. M. Lee, M. K. Chan, Angew. Chem. Int. Ed. 2009, 48, 1633–1635. 
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determine if a salt bridge occurs in these areas, specific glutamate residues could be replaced 
with the synthetic pyrrolysine analog 7. 
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2. Results, Discussion, and Conclusions: Organic Chemistry Studies 
2.1. Taggable Pyrrolysine Analog (7)  
Pyrrolysine analog 7 was synthesized with an overall yield of 20% as depicted in Scheme 1. The 
first three steps were performed without isolating or purifying the intermediates (8-10) to obtain 
ester 11, which was then hydrolyzed with LiOH to give the corresponding lithium carboxylate. 
The product was then treated with KHSO4 to liberate the free acid 12. The other coupling 
partner, the free amine 15, was obtained by first benzylating the carboxyl group of Z-Lys(Boc)-
OH (13), then treating the resulting compound 14 with TFA followed by NaHCO3. Acid 12 and 
amine 15 were subsequently coupled using benzo-(triazol-1-yloxy)tris(dimethylamino)phos-
phonium hexafluorophosphate (BOP) and NMM to give the protected target 16. The 
benzyloxycarbonyl (Z) and benzyl (Bn) protecting groups were then removed by hydrogenation 
to give the desired compound 7 in quantitative yield. The protecting groups, Bn and Z, were 
chosen because, unlike tert-butoxycarbonyl (Boc) or tert-butyl (tBu) protecting groups used in 
the syntheses of other pyrrolysine analogs (see, for example, Chapters 2.2 and 2.3), these groups 
can be removed by hydrogenation as opposed to treatment with an acid. This was important 
because the acetal group of the title compound 7 was expected to be acid sensitive.  
  -4-
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Scheme 1. Synthesis of pyrrolysine analog 7. 
The NMR studies showed that no change to the structure of the pyrrolysine analog 7 
occurred in any of the prepared solutions listed below. 
 (1) 25 mM CH3CO2H buffer (pH 5.2); 
 (2) 50 mM Na2CO3 (pH 11.2); 
 (3) 0.5 M NaOAc buffer (pH 4.1); 
 (4) 0.5 M Na2CO3 (pH 11.4); 
 (5) 1 M TFA (pH 0.5); 
 (6) 0.5 TFA (pH 0.5); 
 (7) 1:1 TFA:D2O; 
 (8) 1:1 TFA:D2O spiked with ethylene glycol; 
 (9) 0.5 M HCl. 
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Pyrrolysine analog 7 was synthesized and then used in biochemical studies. The compound is 
remarkably stable, even under harshly acidic conditions. Attempts to convert the acetal form of 
the analog into the aldehyde form are ongoing. Future attempts to cleave the acetal may include 
treating the compound with a Lewis acid, such as a lanthanide. Another possibility would be to 
make the acetal less stable by inserting a CH2 group between the carbonyl carbon and the acetal 
group, giving the compound shown below. 
 
2.2. Taggable Pyrrolysine Analog (21) 
The taggable pyrrolysine analog 21, N6-(2-oxo-2H-chromene-3-oyl)lysine trifluoroacetate, was 
chosen as a target compound because once incorporated into a protein system, the coumarin 
group would fluoresce and could therefore serve as a tag. Pyrrolysine analog 21 was synthesized 
with an overall yield of 97% as outlined in Scheme 2, and was subsequently used in biochemical 
studies. 
 
Scheme 2. Synthesis of pyrrolysine analog 21. 
2.3. Taggable Pyrrolysine Analog (24) 
The taggable pyrrolysine analog 24, N6-(aminoxyacetoyl)lysine ditrifluoroacetate, was chosen as 
yet another target compound after attempts to cleave the acetal in pyrrolysine analog 7 were 
unsuccessful. If this new analog 24 could read through the UAG codon, it could then be reacted 
with a fluorescent aldehyde-containing dye. This would achieve a similar connectivity to that 
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which would be obtained if 7 was reacted with a fluorescent hydroxylamine-based dye. 
However, this approach is not preferable because an aldehyde-containing dye would have to be 
used in excess. Although it would react preferentially with the strongly nucleophilic protein-
incorporated hydroxylamine-lysine, it would also react with any free NH2 groups of the protein. 
A potential way to avoid these unwanted reactions would be to mop up the excess dye with a 
hydroxylamine derivative. Pyrrolysine analog 24 was synthesized with an overall yield of 98% 
as outlined in Scheme 3, and was subsequently used in biochemical studies. 
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Scheme 3. Synthesis of pyrrolysine analog 24. 
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3. Results, Discussion, and Conclusions: Biochemical Studies 
3.1. Incorporation into mCherry Protein 
The "cherry red" color of the pelleted cells indicated that the taggable pyrrolysine analog 7 was 
incorporated into the full-length mCherry proteins.  
 
 
 
 
 
 
 
 
Figure 2. Incorporation of pyrrolysine analogs 5-7 into mCherry proteins. 
 
 
 
 
 
 
 
 
 
Figure 3. Integrated fluorescence count of analogs 5-7 in mCherry proteins. 
Figures 2 and 3 show the readthrough results for 7 in comparison with two previously 
synthesized pyrrolysine analogs 5 and 6. The results indicate that 7 reads through the UAG 
codon more efficiently than 6 at any concentration. In addition, 7 has a comparable read through 
to 5 at concentrations of 0.2–2 mM, and has a higher read through efficiency than 5 at 5 mM. 
Biochemical studies showed that pyrrolysine analogs 21 and 24 do not read through the UAG 
codon. 
       5                        6                       7  
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3.2. Mass Spectrometry of α-Synuclein Incorporated with Analog (7) 
The incorporation of pyrrolysine analog 7 into a full-length α-synuclein protein was verified by a 
prepared 15% SDS-PAGE gel. Figure 4 shows α-synuclein with 7 at position 44 in lanes 1 and 2. 
Lane 3 in this figure is blank. Lane 4 is the protein marker (bio-rad precision plus). The results 
show that α-synuclein with 7 at position 44 runs between the 20 kD and 25 kD bands. 
 
 
 
 
 
 
 
Figure 4. 15% SDS-PAGE gel of α-synuclein with 7 at position 44. 
The full length sequence for α-synuclein is as follows: 1MDVFMKGLSKAKEGVVAAAEK 
TKQGVAEAAGKTKEGVLYVGSKTKEGVVHGVATVAEKTKEQVTNVGGAVVTGVTA
VAQKTVEGAGSIAAATGFVKKDQLGKNEEGAPQEGILEDMPVDPDNEAYEMPSEEGYQ
DYEPEA140. 
The taggable pyrrolysine analog 7 was incorporated into α-synuclein at position 44 by 
substituting it for threonine. In the mass spectrometry studies, one tryptic peptide observed at 
826.45732+ was identified as 44(7)KEGVVHGVATVAEK58. The theoretical m/z value was 
826.45432+, and the mass error was 3.63 ppm. A detailed MS/MS map of 
44(7)KEGVVHGVATVAEK58 is shown in Table 1. 
Δm (bn – bn–1) Measured m/z Sequence Measured m/z Δm (yn – yn–1) 
  (7)   
129.11 0486.30 Glu, E 1295.49 128.96 
057.00 0543.30 Gly, G 1166.53 057.06 
099.01 0642.31 Val, V 1109.47 099.00 
099.05 0741.36 Val, V 1010.47 099.22 
137.13 0878.49 His, H 0911.36 193.95 
056.99 0935.48 Gly, G   
098.97 1034.45 Val, V 0717.41 099.00 
071.06 1105.51 Ala, A 0618.41 071.14 
100.93 1206.44 Thr, T 0547.27 101.00 
 1       2       3      4 
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099.15 1305.59 Val, V 0446.27 099.09 
070.92 1376.51 Ala, A 0347.18 070.98 
129.08 1505.59 Glu, E 0276.20  
  Lys, K   
Table 1. MS/MS map of 44(7)KEGVVHGVATVAEK58. 
The results indicate that 7 was incorporated into α-synuclein at position 44 in the acetal form 
of the analog shown below. This form is used for mass calculations because the CO–NH bond is 
the most common MS cleavage site in peptides. 
 
If a method to convert the acetal form of analog 7 into the aldehyde form can be found, 
future biochemical studies will be performed with the protein-incorporated analog. Such studies 
would include analyzing the properties of salt bridges between neighboring lysine and glutamate 
residues in certain proteins, such as α-synuclein, by site-specifically substituting glutamate 
residues with the aldehyde form of the analog 7. 
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4. Experimental Methods: Organic Chemistry Studies 
4.1. Synthesis of Taggable Pyrrolysine Analog (7) 
 
Benzyl 1,3-dioxolane-2-carboxylate (11): Following a published procedure for the synthesis of 
methyl 1,3-dioxolane-2-carboxylate,6 excess ozone was bubbled through a solution of 2-vinyl-
1,3-dioxolane (8, 4.7 g, 47 mmol) in methanol (55 mL) at –15 °C for approximately 1 h. The 
resulting solution was added to aqueous 5% NaOH (83 mL) and silver oxide (23.2 g, 99.5 
mmol). After 1 h of rapid stirring, the solution was filtered and the filtrate was washed with ether 
(100 mL). Excess solid CO2 was added into the aqueous layer, which was then evaporated under 
high vacuum to remove the volatiles. The resulting white solid was suspended in hot methanol, 
the suspension was filtered, and the filtrate was evaporated to dryness. The resulting solid, 
benzyl bromide (2.85 g, 16.7 mmol), triethylamine (1.35 g, 13.3 mmol), and DMF (40 mL) were 
combined and stirred for 24 h. The reaction mixture was evaporated under high vacuum. The 
residue was dissolved in CH2Cl2 (100 mL), washed successively with water and brine, and dried 
(MgSO4). The suspension was filtered, and the filtrate was evaporated. Purification by flash 
chromatography (silica gel; hexane/EtOAc, 9/1 → 5/1) gave ester 11 (5.9 g, 30%) as a white 
solid: Rf = 0.60 (hexanes/EtOAc, 1/1). 1H NMR (400 MHz, CDCl3): δ = 3.95–4.17 (m, 4H), 5.19 
(s, 2H), 5.38 (s, 1H), and 7.29–7.45 (m, 5H) ppm. 13C{1H}/13C DEPT-135 NMR (101 MHz, 
CDCl3): δ = 65.3 (CH2), 66.8 (CH2), 98.3 (CH), 128.0 (CH), 128.3 (CH), 128.4 (CH), 135.0 
(ipso C), and 168.1 (ipso C) ppm. IR (CHCl3). vmax = 3019, 3028, 1751, 1282, 1228, 1224, 1221, 
1209, 1205, 1127, and 1037 cm−1. 
 
Benzyl (–)-N2-benzyloxycarbonyl-N6-(tert-butoxycarbonyl)lysinate (14): Acid 13 (10.0 g, 
26.3 mmol) was dissolved in DMF (100 mL) in the dark in a round-bottomed flask with an N2 
inlet. Triethylamine (31.6 g, 0.73 mmol) and benzyl bromide (39.5, 1.45 mmol) were added to 
                                                 
6P. D. Dalsin, J. Hine, J. Am. Chem. Soc. 1972, 94, 6998–7002. 
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the solution and the reaction mixture was stirred for 24 h, evaporated under high vacuum, and 
dissolved in CH2Cl2 (250 mL). The solution was washed successively with water and brine, dried 
(MgSO4), filtered, and evaporated. Purification by flash chromatography (silica gel; 
CH2Cl2/EtOAc, 9/1) gave ester 14 (12.4 g, 68%) as a white solid: [α]20D –5.2 (c 0.9, CHCl3). Rf = 
0.40 (CH2Cl2/EtOAc, 9/1). 1H NMR (400 MHz, CDCl3): δ = 1.34–1.66 (m, 13H), 1.72–2.06 (m, 
2H), 2.93–3.36 (m, 2H), 4.22–4.72 (m, 1H), 4.78–5.09 (m, 1H), 5.12–5.42 (m, 4H), 5.66–6.15 
(m, 1H), and 7.28–7.76 (m, 10H) ppm. 13C{1H}/13C DEPT-135 NMR (101 MHz, CDCl3): δ = 
22.1 (CH2), 28.1 (CH), 29.2 (CH2), 31.6 (CH2), 39.7 (CH2), 53.6 (CH3), 53.8 (CH3), 53.8 (CH3), 
66.6 (CH2), 66.7 (CH2), 78.6 (ipso C), 127.6 (CH), 127.8 (CH), 128.0 (CH), 128.1 (CH), 128.2 
(CH), 128.3 (CH), 135.1 (ipso C), 136.0 (ipso C), 155.3 (ipso C), 155.8 (ipso C), and 172.1 (ipso 
C) ppm. IR (CHCl3). vmax = 1713, 1509, 1240, 1217, 1209, and 1172 cm−1. 
 
Benzyl N2-(benzyloxycarbonyl)lysinate (15): A solution of amine 14 (2.36 g, 5.00 mmol) in 
TFA (5.0 mL), was stirred at room temperature for 1 h. The solution was neutralized with satd 
NaHCO3, and extracted with CH2Cl2. The combined extracts were dried (MgSO4), filtered, and 
evaporated to give the title compound 15 (1.85 g, ~ 100%) as a clear oil that was used 
immediately in the following reaction without any further purification. Amine 15: 1H NMR (400 
MHz, CDCl3): δ = 1.32–1.62 (m, 6H), 2.65–2.95 (m, 2H), 3.54–4.41 (m, 2H), 4.42–4.62 (m, 
1H), 5.10–5.38 (m, 4H), 5.86 (s, 1H), and 7.32–7.55 (m, 10H) ppm. 13C{1H}/13C DEPT-135 
NMR (101 MHz, CDCl3): δ = 22.3 (CH2), 31.2 (CH2), 32.9 (CH2), 40.8 (CH2), 53.8 (CH), 66.8 
(CH2), 66.9 (CH2), 127.9 (CH), 128.0 (CH), 128.1 (CH), 128.3 (CH), 128.3 (CH), 128.4 (CH), 
135.2 (ipso C), 136.2 (ipso C), 155.9 (ipso C), and 172.2 (ipso C) ppm. 
 
Benzyl (–)-N2-Benzyloxycarbonyl-N6-(1,3-dioxolancarbonyl)lysinate (16): A solution of 
benzyl ester 11 (1.04 g, 5.0 mmol) in THF (30 mL) was treated with 1M LiOH (7.5 mL) and the 
reaction mixture was stirred for 30 min. 1M KHSO4 (7.5 mL) was added and the solution was 
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extracted with EtOAc. The combined extracts were dried (MgSO4) and filtered. The filtrate was 
treated with N-methylmorpholine (NMM, 1.1 mL) and evaporated to give the NMM salt of acid 
12 that was used immediately without further purification. 
Subsequently, to a solution of the NMM salt of the acid 12 in CH2Cl2 (50 mL) were added 
amine 15 (1.85 g, 5.0 mmol), NMM (1.2 mL), and BOP (2.43 g, 5.5 mmol). The reaction 
mixture was stirred at room temperature for 22 h, washed successively with water and brine, 
dried (MgSO4), and evaporated in vacuo. Purification by flash chromatography (silica gel; 
EtOAc/hexanes, 2/1→1/1) gave the protected compound 16 ( 2.28 g, 97%) as a clear oil: [α]20D  
–3.4 (c 1.2, CHCl3).  Rf = 0.20 (EtOAc/hexanes, 2/1). 1H NMR (400 MHz, CDCl3): δ = 1.25–
1.91 (m, 6H), 3.21 (dd, J = 12.8 Hz, 6.3 Hz, 2H), 3.90–4.03 (m, 4H), 4.40 (m, 1H), 5.10 (s, 2H), 
5.13 (s, 1H), 5.14–5.25 (ABq, J = 12.3 Hz, 2H), 5.38–5.44 (J = 7.9 Hz, 1H), 6.51 (s, 1H), and 
7.26–7.45 (m, 10H) ppm. 13C{1H}/13C DEPT-135 NMR (101 MHz, CDCl3): δ = 22.1 (CH2), 
28.3 (CH2), 31.4 (CH2), 36.2 (CH2), 53.5 (CH), 65.0 (CH2), 66.5 (CH2), 66.6 (CH2), 98.9 (CH), 
127.6 (CH), 127.7 (CH), 127.8 (CH), 128.0 (CH), 128.1 (CH), 128.2 (CH), 135.0 (ipso C), 135.9 
(ipso C), 155.8 (ipso C), 167.6 (ipso C), and 172.0 (ipso C) ppm. IR (CHCl3). vmax = 3012, 1720, 
1688, 1512, 1348, 1238, 1229, 1223, 1214, 1208, 1189, and 1122 cm−1. 
 
(+)-N6-(1,3-dioxolancarbonyl)lysine (7): A solution of the protected pyrrolysine analog 16 (341 
mg, 0.73 mmol) in MeOH (6 mL) was hydrogenated at normal pressure in the presence of 10% 
Pd/C (72 mg) for 90 min. Water (10 mL) was added, the suspension was passed through a short 
column filled with Celite®, and the filtrate was evaporated in vacuo to give the title compound 7 
(176 g, 99%) as a white solid that was used in biochemical studies without any further 
purification. Compound 7: [α]20D +1.7 (c 1.0, H2O). 1H NMR (400 MHz, CDCl3): δ = 1.30−1.53 
(m, 2H), 1.54–1.73 (m, 2H), 1.76–2.02 (m, 2H), 3.19–3.40 (t, J = 6.9 Hz, 2H), 3.59–3.80 (t, J = 
5.0 Hz, 1H), 4.07 (s, 4H), and 5.32 (s, 1H) ppm. 13C{1H}/13C DEPT-135 NMR (101 MHz, 
CDCl3): δ = 21.8 (CH2), 27.9 (CH2), 30.3 (CH2), 38.7 (CH2), 54.7 (CH), 65.4 (CH2), 98.5 (CH), 
170.0 (ipso C), and 175.2 (ipso C) ppm. 
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4.1.1. pH Stability Studies on Taggable Pyrrolysine Analog (7) 
(1) 1M acetic acid buffer (0.5 mL, pH 4.9) was added to D2O (21.5 mL, 23.65 g) to create a 25 
mM acetic acid buffer (pH 5.2). (2) Na2CO3 (26.5 mg) was added to D2O (5.0 mL, 5.5 g) 
resulting in 50 mM sodium carbonate (pH 11.2). To solutions (1) and (2), analog 7 (5.0 mg) was 
added. 1H NMR studies were performed immediately and again after 24 h. To each NMR 
sample, lysine monohydrochloride (2.0 mg) was added and 1H NMR studies were performed 
again. 
 
(3) 1 M NaOAc buffer (2.5 mL, pH 4.0) was added to D2O (2.5 mL, 2.75 g) to create a 0.5 M 
NaOAc buffer (pH 4.1). (4) Na2CO3 (132.5 mg) was added to D2O (2.5 mL, 2.75 g) to create 0.5 
M Na2CO3 (pH 11.4). (5) TFA (385 μL) was added to D2O (5.1 mL, 5.61 g) to create 1M TFA 
(pH 0.5). (6) TFA (38.5 μL) was added to D2O (5.0 mL, 5.5 g) to create 0.5 M TFA (pH 0.5). (7) 
TFA (0.4 mL) was added to D2O (0.4 mL, 0.44 g) to create a 1:1 solution. (8) TFA (0.4 mL) was 
added to D2O (0.4 mL, 0.44 g) to create a 1:1 solution. Ethylene glycol (2 drops) was added to 
the solution. (9) 12.1 N HCl (80 μL) was added to D2O (2.0 mL, 2.2 g) to create 0.5 M HCl. To 
solutions (3), (4), (5), (6), (7), (8), and (9), analog 7 (2.5 mg) was added. 1H NMR studies were 
performed immediately and again after 24 h. To each NMR sample, lysine monohydrochloride 
(1.0 mg) was added and proton NMR studies were performed again. 
 
4.2. Synthesis of Taggable Pyrrolysine Analog (21) 
 
tert-Butyl (+)-N2-(tert-Butoxycarbonyl)-N6-(2-oxo-2H-chromene-3-oyl)lysinate (20): To a 
solution of coumarin 18 (213 mg, 1.12 mmol) in CH2Cl2 (5 mL) were added amine 19 (339 mg, 
1.12 mmol), NMM (246 μL, 2.24 mmol), and BOP (545 mg, 1.23 mmol). The reaction mixture 
was stirred at room temperature for 24 h and then partitioned between satd NaHCO3 and CH2Cl2. 
The phases were separated and the extraction was completed with additional portions of CH2Cl2. 
The combined organic extracts were dried (MgSO4) and evaporated in vacuo. Purification by 
flash chromatography (silica gel; CH2Cl2/EtOAc, 3/1) gave the titled compound 20 (0.53 g, 97%) 
  -14-
as a white solid: [α]20D +7.5 (c 1.1, CHCl3). Rf = 0.40 (CH2Cl2/EtOAc, 3/1). 1H NMR (400 MHz, 
CDCl3): δ = 1.33–1.79 (m, 24H), 3.32–3.47 (q, J = 6.5 Hz, 2H), 4.04–4.16 (m, 1H), 5.02–5.13 
(d, J = 7.7 Hz, 1H), 7.24–7.38 (m, 2H), 7.54–7.68 (m, 2H), 8.70–8.79 (m, 1H), and 8.83 (s, 1H) 
ppm. 13C{1H}/13C DEPT-135 NMR (101 MHz, CDCl3): δ = 22.5 (CH2), 27.8 (CH3), 28.2 (CH3), 
29.0 (CH2), 32.3 (CH2), 39.4 (CH2), 53.7 (CH), 79.3 (ipso C), 81.5 (ipso C), 116.4 (CH), 118.3 
(ipso C), 118.5 (ipso C), 125.1 (CH), 129.6 (CH), 133.8 (CH), 148.0 (CH), 154.2 (ipso C), 155.2 
(ipso C), 161.2 (ipso C), 161.3 (ipso C), 171.7 (ipso C) ppm. IR (CHCl3). vmax = 3013, 1719, 
1708, 1611, 1570, 1542, 1501, 1456, 1368, 1244, 1209, and 1160 cm−1. 
 
N6-(2-Oxo-2H-chromene-3-oyl)lysine trifluoroacetate (21): The protected pyrrolysine 
analogue 20 (104 mg, 0.22 mmol) in TFA (2 mL) and CH2Cl2 (2 mL) was stirred at room 
temperature for 1 h, and the resulting solution was evaporated in vacuo to give the title 
compound 21·TFA as a white solid (95 mg, ~100%) that was used in the subsequent biochemical 
studies without any further purification. Acid 21·TFA: 1H NMR (400 MHz, CDCl3): δ = 1.27–
1.92 (m, 7H), 3.25–3.42 (m, 2H), 3.84–3.97 (m, 1H), 7.40–7.57 (m, 2H), 7.70–7.81 (t, J = 7.2 
Hz, 1H), 7.94–8.05 (d, J = 7.1 Hz, 1H), 8.19–8.48 (m, 2H), and 8.58–9.04 (m, 2H) ppm. 
13C{1H}/13C DEPT-135 NMR (101 MHz, CDCl3): δ = 21.8 (CH2), 28.4 (CH2), 29.6 (CH2), 38.6 
(CH2), 51.8 (CH), 116.0 (CH), 118.4 (ipso C), 118.9 (ipso C), 125.1 (CH), 130.2 (CH), 134.0 
(CH), 147.3 (CH), 153.8 (ipso C), 160.3 (ipso C), 161.0 (ipso C), 171.0 (ipso C) ppm. 
 
4.3. Synthesis of Taggable Pyrrolysine Analog (24) 
 
tert-Butyl (+)-N2-(tert-Butoxycarbonyl)-N6-(N-tert-butoxycarbonylaminoxyacetoyl)lysinate 
(23): To a solution of acid 22 (235 mg, 1.23 mmol) in CH2Cl2 (5 mL) were added amine 19 (372 
mg, 1.23 mmol), NMM (297 μL, 2.71 mmol), and BOP (598 mg, 1.35 mmol). The reaction 
mixture was stirred at room temperature for 9 h, washed with satd NaHCO3 and extracted with 
  -15-
CH2Cl2. The combined extracts were dried (MgSO4) and evaporated in vacuo. Purification by 
flash chromatography (silica gel; EtOAc/hexanes, 1/1 → EtOAc) gave the protected compound 
23 (575 mg, 98%) as a clear oil: [α]20D +3.5 (c 0.6, CHCl3). Rf = 0.70 (EtOAc). 1H NMR (400 
MHz, CDCl3): δ = 1.26–1.74 (m, 33H), 3.11–3.30 (q, J = 6.5 Hz, 2H), 3.98–4.14 (m, 1H), 4.21 
(s, 2H), 4.99–5.14 (d, J = 7.7 Hz, 1H), 8.12 (s, 1H), and 8.46 (s, 1H) ppm. 13C{1H}/13C DEPT-
135 NMR (101 MHz, CDCl3): δ = 22.4 (CH2), 27.8 (CH3), 28.0 (CH3), 28.2 (CH3), 28.8 (CH2), 
32.2 (CH2), 38.5 (CH2), 53.7 (CH), 75.9 (CH2), 79.4 (ipso C), 81.6 (ipso C), 82.4 (ipso C), 155.3 
(ipso C), 157.8 (ipso C), 168.8 (ipso C), and 171.8 (ipso C) ppm. IR (CHCl3). vmax = 3025, 3015, 
1730, 1709, 1602, 1370, 1252, and 1156 cm−1. 
H
N
O
CO2tBu
NHBoc
BocHNO
TFA, CH2Cl2
H
N
O
CO2H
NH3
H3NO
~100%
23 24
2CF3CO2
 
(+)-N6-(Aminoxyacetoyl)lysine Ditrifluoroacetate (24): The protected pyrrolysine analogue 23 
(338 mg, 0.71 mmol) in TFA (5 mL) and CH2Cl2 (5 mL) was stirred at room temperature for 2 h, 
and the resulting solution was evaporated in vacuo to give the title compound 24·2TFA as a 
white solid (155 mg, ~100%) that was used in the subsequent biochemical studies without any 
further purification. Pyrrolysine analog 24·2TFA: [α]20D +10.7 (c 2.0, MeOH). 1H NMR (400 
MHz, CDCl3): δ = 1.45–1.66 (m, 4H), 1.86–2.06 (m, 2H), 3.15–3.45 (m, 3H), 3.90–4.05 (t, J = 
6.4 Hz, 1H), 4.46 (s, 2H), and 5.12 (m, 7H) ppm. 13C{1H}/13C DEPT-135 NMR (101 MHz, 
CDCl3): δ = 21.9 (CH2), 28.4 (CH2), 29.7 (CH2), 38.2 (CH2), 52.5 (CH), 71.7 (CH2), 112.3–
121.0 (q, J = 292 Hz, ipso C), 160.9–162.0 (q, J = 35.4 Hz, ipso C), 168.9 (ipso C), and 170.5 
(ipso C) ppm. 
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5. Experimental Methods: Biochemical Studies 
5.1. Incorporation of Pyrrolysine Analogs into mCherry Protein 
The plasmids encoding the pPylST-mCherry with a UAG codon mutation at position 55 were 
transformed into E. coli BL21(DE3). Cells were grown in Lauria–Bertani (LB) broth containing 
100 μg/ml ampicillin at 37 °C. At OD600 ~ 1.2, cells were induced with 0.3 mM IPTG and 
supplemented with 15 mM of the pyrrolysine analog for 3 h to promote the overexpression of 
mCherry. The cells were then pelleted by centrifugation at 5000 x g for 15 min. 
 
5.2. Incorporation of Analog (7) into α-Synuclein and MS Studies 
The plasmids encoding the pPylST-α-synuclein with a UAG codon mutation at position 44 were 
transformed into E. coli BL21(DE3). Cells were grown in 2xYT liquid medium containing 100 
μg/ml ampicillin at 37 °C. At OD600 ~ 0.6, cells were induced with 0.5 mM IPTG and 
supplemented with 8 mM of the pyrrolysine analog 7 for 4 h to promote the overexpression of α-
synuclein. The cells were pelleted and lysed by sonication. The supernatant lysate was boiled at 
90 °C for 10 minutes, followed by centrifugation at 15000 x g for 30 minutes to precipitate 
unwanted proteins. The supernatant after the boil was loaded onto a 15% SDS-PAGE gel to 
verify the incorporation of the pyrrolysine analog into the full-length α-synuclein. For mass 
spectroscopy studies, the α-synuclein band was sliced from gel and digested with chymotrypsin. 
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Appendix: Copies of 1H and 13C NMR Spectra 
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